Author

Aaron Yam

Pfizer (United States)

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Immunology· 2

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 2 Research Focus:host-pathogen & immune response· 2 Organism:human· 1 Organism:mouse· 1 Assay:proteomics· 1

Frequent Co-Authors

Alexander MuikiD· 2 shared Annaliesa S. AndersoniD· 2 shared Carla Iris Cadima Couto· 2 shared Kayvon ModjarradiD· 2 shared Kena A. SwansoniD· 2 shared Kristin R. TompkinsiD· 2 shared Lyndsey T. MartineziD· 2 shared Raquel Munoz Moreno· 2 shared

Activity by Year

2025-2026 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersImmunology

Alexander MuikORCID

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Preclinical immunogenicity of the LP.8.1-adapted BNT162b2 COVID-19 vaccine

Chaitanya Kurhade, Wei J. Chen, Weiqiang Li, Kristin R. Tompkins, Lyndsey T. Martinez, Swati Rajput, Emily Babiarz, Aaron Yam, Shin-Ae Lee, Shikha Shrivastava, Sarah O’Leary, Subrata Saha, Hui Qing Yao, Hao Li, Todd S. Coffey, , Kayvon Modjarrad

This study evaluates the immunogenicity of an LP.8.1-adapted BNT162b2 vaccine against JN.1 sublineages, showing higher neutralizing antibody responses compared to other adapted vaccines.

npj Vaccines · Jul 6, 2026Peer-reviewedImmunology

Immunologic and Biophysical Features of the BNT162b2 JN.1- and KP.2-Adapted COVID-19 Vaccines

Wei J. Chen, Kristin R. Tompkins, Ian W. Windsor, Lyndsey T. Martinez, Minah Ramos, Weiqiang Li, Shikha Shrivastava, Swati Rajput, Jeanne S. Chang, Parag V. Sahasrabudhe, Kimberly F. Fennell, Thomas J. McLellan, Graham M. West, Kristianne P. Dizon, Aaron Yam, , Kayvon Modjarrad

Omicron JN.1- and KP.2-adapted BNT162b2 mRNA vaccines elicit stronger neutralizing antibody responses against circulating sublineages than previous vaccines, supporting annual strain updates.

Nature Communications · Dec 5, 2025Peer-reviewedImmunology